Revman 5.3 and TSA 0.9.5.10 Beta were used for the meta-analysis and TSA.



Revman
The purpose of this study is to evaluate the combination of iguratimod (IGU) and methylprednisolone (MP) for the efficacy and safety of primary Sjögren's syndrome (pSS) by a meta-analysis and a trial sequential analysis (TSA).


 Revman 5.3 and TSA 0.9.5.10 Beta were used for the meta-analysis and TSA.


 TSA presented that these benefits observed with the current information volume were all conclusive, except for IgM.  And TSA indicated that the results need to be confirmed by additional studies. 
TSA